ICU Medical completed its acquisition of Smiths Medical, which makes medical devices such as syringes, IVs and vascular access catheters. As payment, ICU Medical issued 2.5 million shares worth $500 million and paid $1.85 billion in cash. The agreement also includes a $100 million contingent consideration, subject to stock price performance and other conditions.